You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NMDA

Showing 1 - 25 of 797
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bipolar I Disorder Trial (NMDAE, Placebo Cap)

Not yet recruiting
  • Bipolar I Disorder
  • (no location specified)
Aug 3, 2023

Schizophrenia Trial in Taichung (NMDAE, Placebo Cap)

Not yet recruiting
  • Schizophrenia
  • Taichung, Taiwan
    Department of Psychiatry, China Medical University Hospital
Sep 4, 2023

SCI Trial in Hines (hypoxia, sham hypoxia, D-cycloserine)

Recruiting
  • SCI
  • hypoxia
  • +4 more
  • Hines, Illinois
    Edward Hines Jr. VA Hospital, Hines, IL
Jan 27, 2023

Schizophrenia Trial in Taichung (NMDAE plus AIFA, NMDAE plus Placebo Cap)

Recruiting
  • Schizophrenia
  • NMDAE plus AIFA
  • NMDAE plus Placebo Cap
  • Taichung, Taiwan
    Department of Psychiatry, China Medical University Hospital
Jul 19, 2022

Schizophrenia Trial in Taichung (NMDAE, Placebo Cap)

Recruiting
  • Schizophrenia
  • Taichung, Taiwan
    Department of Psychiatry, China Medical University Hospital
Mar 9, 2022

Monitoring Drug Efficacy in Patients With Alzheimer's Disease

Recruiting
  • Alzheimer Disease
  • AChE inhibitor monotherapy
  • AChE inhibitor and NMDA receptor antagonist combination therapy
  • Manila, Metro Manila, Philippines
    Philippine General Hospital
Mar 24, 2023

MDD Trial in Taichung (NMDAE, Placebo Cap)

Recruiting
  • Major Depressive Disorder
  • Taichung, Taiwan
    Department of Psychiatry, China Medical University Hospital
Jan 25, 2022

Schizophrenia Trial in Taichung (NMDAE plus AIFA, NMDAE plus Placebo Cap)

Recruiting
  • Schizophrenia
  • NMDAE plus AIFA
  • NMDAE plus Placebo Cap
  • Taichung, Taiwan
    Department of Psychiatry, China Medical University Hospital
Feb 23, 2022

Omega 3 Fatty Acids, Dementia Trial in Kaohsiung (DAOIB+Omega-3, DAOIB+Placebo)

Not yet recruiting
  • Omega 3 Fatty Acids
  • Dementia
  • Kaohsiung, Taiwan
    Kaohsiung Chang Gung Memorial Hospital
Dec 23, 2021

Therapy of Anti-NMDAR Encephalitis at Diagnosis

Active, not recruiting
  • Anti-NMDA (N-Methyl D-Aspartate) Receptor Encephalitis
    • Rotterdam, Netherlands
      Erasmus Medical Center
    Sep 4, 2023

    Prodromal Schizophrenia Trial in Taichung (NMDAE, Placebo Cap)

    Recruiting
    • Prodromal Schizophrenia
    • Taichung, Taiwan
      Department of Psychiatry, China Medical University Hospital
    Nov 2, 2021

    Clinical-immunological Features of Anti-NMDAR Encephalitis

    Active, not recruiting
    • Anti NMDA Receptor Encephalitis
    • Description of clinical characteristic
    • Lyon, Bron, France
      Hôpital Neurologique Pierre Wertheimer / Groupement Hospitalier
    Feb 12, 2023

    MDD Trial in Taichung (NMDAE, Sertraline, Placebo Cap)

    Recruiting
    • Major Depressive Disorder
    • Taichung, Taiwan
      Department of Psychiatry, China Medical University Hospital
    Nov 16, 2021

    Anti-NMDAR Encephalitis Trial in Paris (IA session, Rituximab)

    Recruiting
    • Anti-NMDAR Encephalitis
    • Paris, France
      Hôpital Necker Enfants-Malades
    Oct 31, 2022

    Disorder of Consciousness, Traumatic Brain Injury Trial in New York (Amantadine + L-DOPA, NMDA blocker)

    Suspended
    • Disorder of Consciousness
    • Traumatic Brain Injury
    • Amantadine + L-DOPA
    • NMDA blocker
    • New York, New York
      Weill Cornell Medicine
    Sep 27, 2022

    Borderline Personality Disorder Trial in Melbourne (NMDA receptor antagonist (active drug), Lactose packed capsule

    Recruiting
    • Borderline Personality Disorder
    • NMDA receptor antagonist (active drug)
    • Lactose packed capsule (inert/inactive arm)
    • Melbourne, Victoria, Australia
      Monash Alfred Psychiatry Research Centre
    Sep 27, 2022

    MDD Trial in London (MIJ821)

    Not yet recruiting
    • Major Depressive Disorder
    • London, United Kingdom
      Parexel Early Phase Clinical Unit (LONDON)
    Dec 18, 2022

    Alzheimer Trial in Kaohsiung (DAOI-A group, DAOI-B group, DAOI-C group)

    Completed
    • Alzheimer Disease
    • DAOI-A group
    • +3 more
    • Kaohsiung, Taiwan
      Kaohsiung Chang Gung Memorial Hospital
    Aug 24, 2021

    PTSD, Alzheimer, Brain Diseases Trial in Liège (Fluoroethylnormemantine (FENM))

    Not yet recruiting
    • PTSD
    • +5 more
    • Fluoroethylnormemantine (FENM)
    • Liège, Belgium
      CHU of Liège - Clinical Pharmacology Unit
    Jun 23, 2023

    Chronic Pain, Pain Syndrome Trial in Leiden (drug, behavioral, other)

    Completed
    • Chronic Pain
    • Pain Syndrome
    • Leiden, South Holland, Netherlands
      Leiden University
    Jan 10, 2022

    Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant Trial in Saint Louis (Nitrous Oxide, Placebo gas, MRI)

    Terminated
    • Depressive Disorder, Major
    • Depressive Disorder, Treatment-Resistant
    • Nitrous Oxide
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jul 29, 2021

    Cannabis, Ketamine Trial in West Haven (Active Delta-9-THC, Placebo Delta-9-THC, Active Ketamine)

    Recruiting
    • Cannabis
    • Ketamine
    • Active Delta-9-THC
    • +3 more
    • West Haven, Connecticut
      VA Connecticut Healthcare System
    Jan 27, 2022

    Paraneoplastic Neurologic Encephalitis and Mature Cystic

    Recruiting
    • Ovarian Dermoid Cyst
    • Blood sample
    • Rishon LeZion, Israel
      Shamir medical center
    Jan 23, 2022

    Opioid Use Disorder Trial in New Haven (NYX-783, Placebo, Oxycodone)

    Not yet recruiting
    • Opioid Use Disorder
    • New Haven, Connecticut
    • +1 more
    Dec 2, 2022

    Depressive Disorder, Major Trial in Kaohsiung, Taichung (NMDA, Sertraline, Placebo - Cap)

    Completed
    • Depressive Disorder, Major
    • NMDA
    • +2 more
    • Kaohsiung, Taiwan
    • +1 more
    Nov 29, 2020